TESAMORELIN

TESAMORELIN

$340.000,00 COP
Skip to product information
TESAMORELIN

TESAMORELIN

$340.000,00 COP

What is it?

Tesamorelin is an analog of growth hormone-releasing hormone (GHRH).

What is it used for?

Tesamorelin does have a specific approved medical indication in the United States: Egrifta WR is indicated to reduce excess abdominal fat in adults with HIV and lipodystrophy.

Benefits studied/approved

  • Stimulation of growth hormone production.

  • Reduction of abdominal fat in the specific population for which it is approved.

  • Research related to body composition.

Other